Senex Biotechnology

Timeline

1. Dec 13, 2024 Grant Government grant — STTR: $400,000 (annual award, as published), announced Dec 13, 2024. Agency: NIH/NCI. Source: government award database. source ↗

Funding

Last 2 years.

• Dec 13, 2024 Government grant — STTR: $400,000 (annual award, as published), announced Dec 13, 2024. Agency: NIH/NCI. Source: government award database. source ↗

NIH awards 15

Annual award amounts. Total $6.4M.

• Sep 12, 2022 NIH award 1R43CA271996-01A1 FY2022: $400,000 awarded for that fiscal year; activity R43 (SBIR); PI CHEN, MENGQIAN; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Preventing in vivo resistance to PI3K/ source ↗
• May 28, 2021 NIH award 5R44CA203184-03 FY2021: $846,340 awarded for that fiscal year; activity R44 (SBIR); PI CHEN, MENGQIAN; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK8/19 inhibitors for therapy of advanc source ↗
• May 13, 2020 NIH award 2R44CA203184-02A1 FY2020: $1,130,935 awarded for that fiscal year; activity R44 (SBIR); PI CHEN, MENGQIAN; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK8/19 inhibitors for therapy of ad source ↗
• Aug 24, 2017 NIH award 1R43HL137525-01 FY2017: $299,151 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Targeting CDK8 for the treatment of v source ↗
• Jun 28, 2017 NIH award 1R43CA221485-01 FY2017: $299,993 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK8/19 inhibitor for the treatment o source ↗
• Dec 29, 2016 NIH award 1R43CA213629-01 FY2017: $299,891 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Enhancing cytarabine efficacy in leuk source ↗
• Sep 23, 2015 NIH award 1R43CA203184-01 FY2015: $240,750 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK8/19 inhibitors for therapy of adv source ↗
• Aug 21, 2012 NIH award 5R44CA141845-03 FY2012: $473,945 awarded for that fiscal year; activity R44 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK3-inhibiting anticancer agents source ↗
• Sep 27, 2011 NIH award 2R44CA141845-02 FY2011: $1,064,678 awarded for that fiscal year; activity R44 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK3-inhibiting anticancer agents source ↗
• Sep 29, 2009 NIH award 3R44CA139991-03S1 FY2009: $200,000 awarded for that fiscal year; activity R44 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Inhibitors of disease-promoting act source ↗
• Aug 25, 2009 NIH award 5R44CA139991-03 FY2009: $191,028 awarded for that fiscal year; activity R44 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Inhibitors of disease-promoting activ source ↗
• Jun 22, 2009 NIH award 1R43CA141845-01 FY2009: $107,000 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. CDK3-inhibiting anticancer agents source ↗
• Sep 26, 2008 NIH award 9R44CA139991-02A1 FY2008: $611,473 awarded for that fiscal year; activity R44 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Inhibitors of disease-promoting act source ↗
• Jan 21, 2008 NIH award 1R43GM081968-01A1 FY2008: $107,001 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., COLUMBIA, SC. Small Molecules Inducing BTG1 Trans source ↗
• Jul 18, 2006 NIH award 1R43AG029023-01 FY2006: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI PORTER, DONALD C.; recipient as written: SENEX BIOTECHNOLOGY, INC., Columbia, SC. Inhibitors of disease-promoting activ source ↗